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Dresden, Dresden, GermanyABSTRACT Pores made by amphipathic cationic peptides (e.g., antimicrobials and fragments of pore-forming proteins) are
typically studied by examining the kinetics of vesicle leakage after peptide addition or obtaining structural measurements in
reconstituted peptide-lipid systems. In the first case, the pores have been considered transient phenomena that allow the relax-
ation of the peptide-membrane system. In the second, they correspond to equilibrium structures at minimum free energy. Here
we reconcile both approaches by investigating the pore activity of the a5 fragment from the proapoptotic protein Bax (Baxa5)
before and after equilibrium of peptide/vesicle complexes. Quenching assays on suspensions of large unilamellar vesicles
suggest that in the presence of Baxa5, the vesicles maintain a leaky state for hours under equilibrium conditions. We proved
and analyzed stable pores on single giant unilamellar vesicles (GUVs) in detail by monitoring the entrance of dyes added at
different times after incubation with the peptide. When the GUVs came in contact with Baxa5, leakage started stochastically,
was delayed for various periods of time, and in the majority of cases proceeded rapidly to completion. After hours in the presence
of the peptide, the same individual GUVs that refilled completely at first instance maintained a porated state, which could be
observed in subsequent leak-in events for serially added dyes. However, these long-term pores were smaller in size than the
initial equilibration pores. Stable pores were also detected in GUVs made in the presence of Baxa5. The latter pores can be
considered equilibrium states and may correspond to structures measured previously in bilayer stacks. Although pore formation
may occur as a kinetic process, equilibrium pores may also be functionally relevant structures, especially in highly regulated
systems such as the apoptotic mitochondrial pores induced by Bax.INTRODUCTIONAmphipathic cationic polypeptides of varying complexity
and functions, including peptide antibiotics (1) and apo-
ptotic Bcl2 proteins (2) or fragments thereof (3–6), interact
with lipid membranes and increase their permeability to
polar solutes. The mechanisms that lead to membrane
leakage are poorly understood (3), but have been described
by a variety of models in which an as yet unknown active
structure is usually defined as a pore (1,7). The majority
of such models are supported by investigations of pore
activity, such as kinetic studies of the leakage of fluores-
cence probes in ensembles of large unilamellar vesicles
(LUVs) (8) or individual giant unilamellar vesicles
(GUVs) (9,10). The recorded kinetics results from multiple
overlapping equilibration processes such as peptide diffu-
sion, binding to the membrane, structural reorganization
of the complex, pore formation, and finally the release of
the probe. Thus, the activity-based or kinetic models refer
essentially to the mechanism of pore formation in close
connection to the equilibration of the peptide-vesicle
complexes (11,12). The initial binding of the peptide at
the interface of the accessible (external) monolayer, calledSubmitted May 13, 2010, and accepted for publication August 26, 2010.
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0006-3495/10/11/2917/9 $2.00the Bex state (9,13) (Fig. 1 A, left), is considered to cause
mass imbalance and asymmetric area stretching. Above
a critical mole fraction of bound peptide, the Bex state
evolves cooperatively and stochastically for each individual
vesicle into a porated Pi state (9,13). The pores are assumed
to be disordered or chaotic structures (13,14), probably
related to the so-called toroidal pores (11,15), lined by lipids
and peptides (Fig. 1 A, right), as described by molecular-
dynamics simulations (16,17). Such a mechanism is
reminiscent of the two-stage process that was recently
proposed for the activity of the CM15 antimicrobial peptide
on individual bacteria, as studied by high-speed atomic
force microscopy (18). Because the leakage kinetics is
related to the relaxation of the membrane after a peptide
attack, pores are naturally viewed as transient structures
(11,12,16,19–21). Nevertheless, in most cases studied, the
pores are sufficiently long-lived to allow for complete
release of vesicle-entrapped dyes, and are thus said to follow
an all-or-none release mechanism (8,9,19,20,22,14).
Although natural peptide-induced pores in cells appear to
occur as kinetic processes (18,23), equilibrium pores may
also be physiologically relevant (24). Moreover, long-term
and equilibrium structures can be important for pores
made by proteins such as Bcl-2 family members and bacte-
rial toxins (25), which are complex and highly regulated
phenomena and may function as stable assemblies. Another
reason to investigate pores at equilibrium is that molecular
models cannot be easily deduced from kinetic studies only
(8,13,26,27). Structural investigations of peptide-membranedoi: 10.1016/j.bpj.2010.08.068
FIGURE 1 Cartoons of kinetic, two-state (Bex/Pi), and equilibrium
two-phase (S/I) pore models. (A) The initial asymmetric binding-refolding
of active peptides at the membrane interface (Bex state) drives the transition
to a pore Pi state (9,13). (B) At equilibrium the peptide is bound interfa-
cially to both monolayers, causing area expansion and membrane thinning
(10,30) (S-phase). Above a threshold P/L ratio, it coexists with a different
molecular organization (7,26) (I-phase) corresponding to observable
toroidal pores (31). The particular organization of peptides is unknown
(the one chosen for this model is arbitrary).
2918 Fuertes et al.systems have been performed on supported multibilayer
stacks made from equilibrated peptide/lipid mixtures.
Oriented circular dichroism (28) and NMR (29) reveal
a change in the orientation of peptide helices from a flat,
S, to a tilted/inserted, I, alignment, past a threshold
peptide/lipid molar ratio, P/L* (7,15,30). These peptide-
tilt states (7) were recently reformulated as two phases
(26), modeled schematically in Fig. 1 B. The S-phase corre-
sponds to interfacial binding of the peptide and is accompa-
nied by an increase in the interfacial area (10) and
concomitant membrane thinning (30). Because the system
is measured at equilibrium and reconstituted from a homoge-
neous mixture, the peptide should be bound equally to both
monolayers. At P/L > P/L*, the S-phase coexists with the
I-phase, and in these conditions stable pores can be detected
by neutron and x-ray scattering (15,30). The lipidic outline
of toroidal pores induced by an a5 fragment of the apoptotic
protein Bax (Baxa5) was recently obtained by x-ray diffrac-
tion of bilayer stacks containing brominated lipids (31). The
peptide molecules associated to such a lipidic pore were not
observed in the x-ray studies, but it was assumed that they
bind close to the pore rim and correspond to the tilted
peptide state that defines the I-phase.
The connection between kinetic and equilibrium pores is
unclear, and the relationship between the postulated Bex/
Pi transition (9,13) and two-phase S/I model (7,26) remains
undefined. Two attempts have been made to correlate kinetic
and equilibrium pores. Preequilibrium magainin pores in
vesicles, detected by cryo-electron microscopy, were found
to be comparable to those studied by neutron scattering in
equilibrated bilayer stacks (32). On the other hand, theBiophysical Journal 99(9) 2917–2925time-dependent area expansion of single GUVs due to me-
littin binding was correlated to the membrane thinning
observed at equilibrium (10). However, the kinetics of equi-
librium pores has not yet been characterized.
Here, we describe vesicle poration by a Baxa5 fragment
at long term and under equilibrium. The protein Bax is a
critical regulator of physiological cell death in mammals.
It controls the release of mitochondrial apoptotic proteins
(33), which is believed to proceed through toroidal proteoli-
pidic pores (34,35). The Baxa5 peptide acts as a minimal
active fragment that is able to release cytochrome c from
isolated mitochondria (4). In previous studies, investigators
examined slightly longer versions in vesicle leakage exper-
iments out-of-equilibrium and ion channels in black lipid
membranes, and concluded that they induce toroidal pores
(5,6,36). Reconstituted in different types of supported bila-
yers, the peptides were observed to exhibit a tilted orienta-
tion (5) and reduce the membrane line tension (36). The
lipidic structure of peptide-induced toroidal pores was
determined by x-ray diffraction (31). Our experiments in
LUV suspensions suggested that Baxa5 forms stable pores
at equilibrium, and we subsequently proved this through
the direct observation of individual GUVs over long periods
of time after peptide addition. We propose that the activities
of long-term and equilibrium pores reported here corre-
spond to the structures investigated in bilayer stacks, and
we demonstrate that these pores differ from preequilibrium
kinetic pores at least in terms of size.MATERIALS AND METHODS
Lipids, fluorescence probes, and peptides
For this study, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzox-
adiazol-4-yl) (NBD-PE), and bovine brain cardiolipin (CL) were purchased
from Avanti Polar lipids (Alabaster, AL). Calcein, sodium dithionite, and
1,1,1,3,3,3-hexafluoroisopropanol (HFIP) were obtained from Sigma-
Aldrich (St. Louis, MO). 1,19-Dioctadecyl-3,3,39,39-tetramethylindodicar-
bocianin (DiD), Alexa488, Alexa555, and AlexaFluor647 succinimidyl
ester were obtained from Molecular Probes/Invitrogen (Eugene, OR).
Atto655 was purchased from Atto-Tec (Germany).
Baxa5 encompasses helix 5 of human Bax (37), with sequence
WGRVVALFYFASKLVLKALSTK, where Ser-20 substitutes the natural
Cys to avoid dimerization. It was synthesized and purified as described
previously (5). The unlabeled peptide was acetylated at the N-terminus
and amidated at the C-terminus. For the fluorescence-labeled peptide, the
N-terminus was kept free and subsequently coupled to Alexa647 succini-
midyl ester directly in the synthesis column. Peptide stock solutions were
prepared in HFIP to avoid aggregation, and aliquots were diluted in phos-
phate-buffered saline (PBS) immediately before use to minimize the
amount of organic solvent added to the vesicles. Peptide concentrations
were determined by UV-Vis absorbance (3280 ¼ 6990 M1cm1).Leakage assays with LUVs
Calcein release
LUVs with entrapped calcein (80 mM), made of POPC or POPC/CL
(80:20), were prepared in PBS using the extrusion method (38). CL was
Equilibrium Pores of Baxa5 2919used because of the suggested significance of this lipid for the function of
Bax (39). The excess nonencapsulated dye was removed by exchanging
LUVs into fresh PBS through Sephadex-G50 (Sigma-Aldrich) minicol-
umns. Lipid concentrations were determined with the use of a kit from
Wako Chemicals (Japan). Calcein efflux was measured as the relief of
self-quenching from themoment of peptide addition (38), using a spectroflu-
orimeter (Photon Technology International, Japan) with emission at 520 nm
and excitation at 480 nm. The percentage of calcein release at time t after
peptide addition (Rt
%) was calculated from the fluorescence at that time,
Ft, with respect to the minimum fluorescence Fi
min (before peptide addition)
and the maximum fluorescence FN
max (upon addition of Triton X-100),
according to the equation Rt
% ¼ 100  (Ft  Fimin)/(FNmax  Fimin) (5).
Quenching of labeled lipids
LUVs were prepared in PBS with POPC/NBD-PE (99.5:0.5) or POPC/CL/
NBD-PE (79.5:20:0.5) lipids. For vesicles made in the presence of peptide,
the Baxa5 and lipids were initially mixed in organic solvent at the amounts
required. The quenching assay was carried out according to McIntyre and
Sleight (40). LUVs labeled with NBD-PE (0.5 mol%) were diluted in
PBS (pH 7.4) to 5 mM lipids in a 1 mL quartz cuvette and mixed with
the desired amounts of Baxa5. At defined times after mixing, sodium
dithionite was incorporated to a concentration of 20 mM from a 1 M fresh
stock in 1 M Tris-HCl, pH 10. This pH is important to stabilize the reactant
in the stock, but the small aliquots added did not significantly change the pH
in the buffered vesicle suspensions. The fluorescence of NBD-PE was regis-
tered with excitation at 470 nm and emission at 540 nm. The quenching at
time t after dithionite addition was calculated as a percentage (Qt
%), from
the fluorescence at that time, Ft, with respect to the maximum fluorescence
F0
max (before dithionite addition) and the minimum fluorescence FN
min
(upon addition of Triton X-100), according to the equation Qt
% ¼ 100
(F0
max  Ft)/(F0max  FNmin). For comparison with the results of calcein
release, differences between values in the presence (Qt
%,pep) and absence
(Qt
%,mem) of peptide were calculated and expanded to a 0–100% scale as
DQt
% ¼ 2(Qt%,pep  Qt%,mem).
Experiments with single GUVs
POPC/CL GUVs (80:20) were made by electroformation (41). GUVs
prepared in the absence of peptide contained the lipophilic dye DiD
(0.05%) to allow observation of the membrane (42). For GUVs reconsti-
tuted in the presence of peptide, Alexa647-labeled Baxa5 was codissolved
with the lipids at the required amounts. The electroformation chamber was
filled with a ~300 mM sucrose solution, adjusted to be isoosmolar with PBS
from the observation chamber. GUV suspensions were transferred to the
observation chamber in the amounts required for ~6 mM lipids. Such
a concentration was estimated from measurements in batches of GUVs
made in parallel under equal conditions, which were concentrated 10–15
times and analyzed using the kit from Wako Chemicals (Japan).
Confocal microscopy
GUVs were observed at room temperature in multitrack mode on
a LSM510 confocal fluorescence microscope using a C-Apochromat 40
1.2 NA water immersion objective (both from Zeiss, Jena, Germany). For
the first track, the excitation light was from Ar-ion (488 nm) and He-Ne
(633 nm) lasers and the emission was split into two channels and filtered
by a 650 nm long-pass filter (channel 1) and a 505–550 nm band-pass filter
(channel 3). For the second track, the sample was excited with an He-Ne
laser at 543 nm and the emission light was filtered through a 560–615 nm
band-pass filter (channel 2). Images were recorded in grayscale, pseudo-
colored red (channel 1), blue (channel 2), or green (channel 3), and pro-
cessed with the help of ImageJ (http://rsbweb.nih.gov/ij/).
Successive leak-in kinetics
After PBS, Baxa5, and a dye (Alexa555, 1250 Da) were mixed in the obser-
vation chamber, an aliquot of sucrose-loaded GUVs was added. Thevesicles then sank to the bottom of the chamber, where they were observed.
Images were recorded every 10 s and the change in fluorescence intensity
inside individual GUVs was analyzed over time. After 2 h, a second dye
(Alexa488, 640 Da) was added and the dye entry kinetics was again moni-
tored. A third dye (Atto655, 630 Da) was added ~15 min later and its leak-in
kinetics was recorded.
For comparison with successive leak-in events, the volume flux Jv
through the vesicle membrane was determined. For the first leakage, the
fluorescence inside a GUV at any given time (Ft) was normalized (Ft
N)
with respect to the fluorescence at time 0 (F0) and to the almost constant
outside fluorescence (Ft
out), according to Ft
N ¼ (Ft  F0)/(Ftout  F0).
Then, the flux Jv (in mm/min) was obtained from a fit of normalized values
to the exponential equation FNt ¼ 1 e3Jvt =Rt (43), where R is the radius of
the vesicle. For the second and third leakages, however, measurements were
made just after the dye was added, and the outside concentration of the dye
was changed by dilution from the point of addition. In these cases the flux
was determined by a fit to the raw fluorescence with the equation
Ft ¼ F0 þ ðFout0t  F0Þ  ð1 e3Jvt=RÞ. Ftout0 represents the time-depen-
dent outside fluorescence in the immediate surroundings of the vesicle,
modeled by a first-order exponential decay as Fout
0
t ¼ FoutN þ Fout0 ekt, where
F0
out and FN
out are the fitted values of the outside fluorescence at time 0 and
at equilibrium, respectively, and k is the decay constant of the outside fluo-
rescence. The Ft
out0 values from the fits were used to normalize the kinetics
of second and third dyes (see Fig. S1 in the Supporting Material for details).
RESULTS AND DISCUSSION
Capturing long-term and equilibrium pores in
ensembles of LUVs
We performed standard assays of peptide-induced pores in
suspensions of LUVs (38) by recording the release of
entrapped dyes for only a few minutes after peptide addition
(Fig. S2). To capture the activity of pores for long time
periods after peptide/vesicle mixing, we first chose to use
an indirect approach based on quenching of a fluorescent
lipid (0.5% NBD-PE) equally distributed in the two mono-
layers of vesicle membranes as it is reduced by sodium
dithionite (40). In the absence of pores or membrane
defects, this reactant permeates slowly through phospho-
lipid membranes (44,45) and quenching mainly affects the
external monolayer, reaching ~50% (Fig. S3). However,
for leaky membranes the inner monolayer becomes also
accessible to dithionite, yielding higher levels of quenching.
The assay must be performed and interpreted with care,
since apart from pores, membrane defects and lipid flip-
flop may also contribute to increase quenching (44), and
such effects can intensify when amphipathic peptides bind
to the membrane interface. Another reason for caution is
that the quenching kinetics is dominated by the dithionite
reaction (44), which is slower than the rate of vesicle
leakage (compare Fig. S2 and Fig. S3). However, the rate
constant for dithionite reduction may be assumed to be inde-
pendent of the presence of the peptide, and for a given time
after dithionite addition, the increase in quenching with
respect to the absence of peptide should be proportional to
the increased accessibility of NBD-PE.
The increments of normalized NBD-PE quenching 250 s
after dithionite addition (DQ250
%; see Materials and
Methods) in LUVs preincubated with Baxa5 are representedBiophysical Journal 99(9) 2917–2925
FIGURE 2 Short-term, long-term, and equilibrium pore activities in
ensembles in LUVs. (A) LUVs of POPC/NBD-PE (99.5:0.5), P/L 1/500
and 1/50. (B) POPC/CL/NBD-PE (79.5:20:0.5), P/L 1/100 and 1/25. Both
graphs show normalized differences (with peptide, minus without peptide)
of percentages of quenching of NBD-PE 250 s after addition of dithionite,
DQ250
% (see Fig. S3). Baxa5 was either added simultaneously with dithion-
ite (0 h) or preincubated with LUVs for 1 h or 24 h. Alternatively, LUVs
were prepared in the presence of the peptide (reconstituted). Percentages
of calcein release from LUVs 250 s after peptide addition, R250
% (gray;
see Fig. S2), are also shown for comparison. Within each group of experi-
ments (A and B), all data correspond to the same batch of all components
and experiments were run in a single session. Bars correspond to averages
of three repetitions5 the SD.
2920 Fuertes et al.in Fig. 2 for two lipid compositions, each at two P/L ratios.
When Baxa5 and dithionite were added simultaneously to
either POPC/NBD-PE (99.5:0.5) or POPC/CL/NBD-PE
(79.5:20:0.5; Fig. 2, A and B, respectively, white bars), there
was an increment of quenching (DQ250
% > 0) compared to
LUVs in the absence of peptide, indicating that NBD-PE
from the internal monolayer was accessible to dithionite.
The extent of DQ250
% was comparable, within error, to the
calcein release (R250
%) observed under analogous conditions
(Fig. 2, A and B, gray bars), and, of importance, the P/L
dependence was very similar for the two types of experi-
ments. In addition, bothR250
% andDQ250
% decreased compa-
rably in the presence of CL, as expected from previous
studies (5). Altogether, these data indicate that under our
conditions the extra accessibility of dithionite to internal
monolayer lipids in the presence of Baxa5 is due to
peptide-induced membrane permeability and/or to pheno-
mena closely coupled to the presence of pores.
The NBD-PE quenching experiment on vesicles previ-
ously incubated with Baxa5 allowed us to register vesicle
permeability at any stage of an evolved peptide/membrane
system. The results in Fig. 2, A and B (striped bars), show
that the vesicle leaky state was still present at least 24 h after
addition of the peptide. Because the relaxation of initial pore
states may be slow, we repeated the experiments using vesi-
cles reconstituted with Baxa5 (Fig. 2, A and B, dotted bars).
Again, the values of DQ250
% suggest that pores also exist in
this truly equilibrated system. The quenching levels are
similar for long-term incubated and reconstituted Baxa5/
LUVs, and they all are larger than the values obtained
without preincubation with Baxa5; however, these and other
small differences may not be significant, considering theBiophysical Journal 99(9) 2917–2925error of the experiments. The dose-response and lipid-
composition effects of long-term and equilibrium activities
were basically maintained as described above, suggesting
that they were due to peptide-induced pores. In the next
section we demonstrate the existence of such pores in single
GUVs by direct visualization of leakage using fluorescence
microscopy.Successive leakage in single GUVs
The pore activity of peptides and proteins in individual
GUVs can be followed with the use of optical microscopy
techniques (9,10,46,43). By recording the internalization
of fluorescent dyes in selected GUVs (43), these methods
also allow multiple leakage events to be monitored at
specific moments on the same set of vesicles. We use such
a strategy to investigate the permeability of vesicle mem-
branes at short and long times after they come in contact
with the peptide, presenting the GUVs with successively
added external dyes. The vesicle integrity is controlled by
the fluorescence of the inert lipophilic dye (DiD) present
in the membrane (42).
In a typical series of experiments (Fig. 3), a suspension of
GUVs labeled with DiD (red) was added to the observation
chamber containing the first dye (Alexa555; Fig. 3 A, blue)
and Baxa5. Vesicle poration then began in a stochastic way,
in similarity to previous observations regarding the kinetics
of dye release in the presence of magainin 2 (9,13), dye
entrance in the presence of the protein equinatoxin II (43),
and the kinetics of area/volume vesicle expansion induced
by melittin (10). The onset of Baxa5-dependent dye
entrance occurred at various times, mostly between 30 min
and 1 h (see some examples in Fig. 3 E, left). However, as
soon as it started, the dye concentration reached near-
complete equilibration with the outside pool in ~2 min. It
was previously observed that the kinetics of accumulating
leaky vesicles registered for large ensembles of GUVs
from the moment of peptide addition is similar to the
kinetics of contents release from LUV suspensions
(9,13,43). In both types of ensembles, the kinetics corre-
sponds to the onset of pores in the complete vesicle pool,
which at the end point affects a number of vesicles depend-
ing on P/L. Two hours after peptide addition (Fig. 3 B), all
vesicles appear to be intact, but whereas some are
completely refilled with Alexa555 (marked in the image
of the red channel), others are empty of fluorescence probe.
In most refilled vesicles the exchange of contents was
complete, and thus it is clear that they followed an all-
or-none poration mechanism (8,22,47). However, a few
vesicles refilled only partially with dye, because the rate
of entrance was very slow and eventually faded away (see
Fig. S4 and below). Such behavior corresponds to what is
known as graded leakage (8,22,48).
After 2 h of peptide/vesicle equilibration, a second dye
was added (Alexa488, green), whose leak-in is shown in
FIGURE 3 Successive leak-in of serially added
dyes for individual GUVs. Baxa5 and the first
dye (Alexa555, blue) are initially present in the
observation chamber, where GUVs labeled with
DiD (red) are added to P/L ¼ 1/90 (time ¼ 0).
(A) Fluorescence images were recorded starting
from minute 3 in three channels. Eventually
some GUVs became permeable stochastically
and the dye internalized rapidly. Examples of
normalized kinetics for five single GUVs are
shown in E (left). (B) Two hours later, all GUVs
have maintained their integrity (red), but some
(marked with arrows) have allowed complete
entrance of the first dye (compare red and blue
channels). Immediately afterward, a second dye
(Alexa488, green) was added. The same GUVs
as before are still permeable but now refill with
the second dye at slower rates (E, middle). (C)
Images after entrance of the second dye. The leaky
vesicles for this dye (green) are the same as those
for the first dye (blue), marked in the image of the
red channel. Immediately afterward, a third dye
(Atto655, red) is added and its entrance is moni-
tored (E, right). (D) Images taken at 150 min
show that the porated vesicles are still the same
as with the first and second dyes. (E) The influx
kinetics for the second and third dyes are normal-
ized as explained in Fig. S1. (F) Averaged volume
fluxes for 40 GUVs5 SD.
Equilibrium Pores of Baxa5 2921pictures taken 15 min later (Fig. 3 C). Finally, we added
a third dye (Atto655, red), and the response can be seen in
pictures taken again 15 min later (Fig. 3 D). During this
time (150 min in total) we registered the fluorescence
from the same sets of GUVs. The recorded tracks for the
second and third leak-in events, after a careful analysis
accounting for the influence of the diffusive equilibration
of the dyes (Fig. S1), show that the kinetics are slower
than those of the first leakage (Fig. 3 E). For a quantitative
comparison we fit the leak-in kinetics to exponential
functions (43) relating the increase of fluorescence within
the porated GUVs to their measured radius (R) and to the
volume flux of the probe (Jv; see Materials and Methods,
and Fig. S1). Fits of kinetic traces for a total of 40
GUVs yielded average flux values for the second (2.0 5
1.3 mm/min) and third (2.6 5 1.8 mm/min) dyes that were
smaller than those for the first dye (4.3 5 1.9 mm/min;
Fig. 3 F). In addition, we made two clear and remarkable
observations:
1. For all leaky vesicles, the entrance of the second and
third dyes started with no significant delay, showingthat all porated vesicles were already in that state at the
moment these dyes were added.
2. All of these porated vesicles were individual vesicles that
were completely permeable to the first dye. Additionally,
all vesicles that were initially nonpermeable to the first
dye remained sealed for the second and third dyes, and
the few vesicles that exhibited partial first dye entrance
showed no entrance of successive dyes (Fig. S4).
The numbers of tracked vesicles and porated and nonpo-
rated vesicles for each dye and for three P/L ratios are given
in Table S1. For small P/L cases, there is a fraction of vesi-
cles showing partial or graded first-dye exchange (~22% of
all porated for P/L ¼ 1/720) and eventually pore closure
(Fig. S4 E), i.e., graded leakage appears to be a kinetic
mechanism that is linked to peptide/membrane equilibra-
tion. On the other hand, the fact that graded filling and
all-or-none filling coexist during the equilibration process
shows that both mechanisms can occur simultaneously for
a given peptide/lipid system, as previously suggested (49).
It should also be noted that the vesicle pool contains an
intrinsic, small percentage of porated vesicles (~8%) inBiophysical Journal 99(9) 2917–2925
FIGURE 4 P/L dependence of Baxa5 poration on GUVs, and Baxa5
binding and activity in reconstituted systems. (A) Dose-response graphs
for the leak-in of externally added dyes. The open circles are percentages
of GUVs that were permeable to the first dye (Alexa488) during the first
2 h after they came in contact with Baxa5 (including completely and
partially filled GUVs); the dose-response curve for any successive dye
entrance is slightly different (solid circles). The percentage of completely
permeable GUVs in the first leakage event, relative to the total permeable
GUVs (including partially porated), is represented by squares. Triangles
indicate data for the entrance of external Alexa488 at equilibrium,
measured with GUVs prepared in the presence of Alexa647-labeled
Baxa5. Images of the latter GUVs for three P/L ratios are shown in B,
demonstrating accumulation of the Alexa647-Baxa5 peptide in the
membrane (left column) and peptide-induced leakage of Alexa488 (right
column). See also controls in Fig. S5.
2922 Fuertes et al.the absence of peptide that exhibit both all-or-none and
graded filling (Table S1 and values at P/L ¼ 0 in
Fig. 4 A), suggesting that at least for the lipid composition
used here, the coexistence of both types of mechanisms is
a characteristic of lipidic pores.
We also analyzed the dependence of the proportion of
Baxa5 porated GUVs on P/L. Plotted using all porated vesi-
cles for the leak-in of the first dye up to the first 2 h (Fig. 4 A,
open circles), the dose-response graph is similar to that
measured in calcein-release assays using LUV suspensions
(5). Because a few such vesicles (exhibiting graded filling)
did not remain in the porated state, the plots for successive
dye entrances are slightly different (Fig. 4 A, solid circles).
The number of partially (transiently) porated vesicles also
depends on P/L. Thus, from the data of the first leakage event
we can also plot the percentage of stably porated vesicles
relative to the total number of porated vesicles (stable and
transient), which reaches 100% near P/L ¼ 1/100 (Fig. 4 A,
squares). The latter P/L ratio appears reminiscent of
threshold values reported in previous studies of other systems
(10,13,30,31), and they are also of a similar magnitude.Pores in reconstituted GUVs
A difference between LUVs and GUVs is that the latter type
of vesicles, of much larger size, tends to be more fragile.
Thus, to avoid artifacts, leakage events on GUVs were not
registered at very long times after they came in contactBiophysical Journal 99(9) 2917–2925with the peptide. Instead, as we also did with LUVs, we
prepared equilibrated systems by reconstituting GUVs in
the presence of Baxa5. Additionally, for these samples we
used a fluorescence-labeled version of the peptide
(Alexa647-Baxa5) that allowed us to directly test membrane
binding. The bright fluorescence of themembrane in the pres-
ence of Alexa647-Baxa5 (Fig. 4 B, left), compared with the
weak signal in the presence of Alexa647 alone (control
experiment, Fig. S5 A), shows peptide binding to the bilayer.
Furthermore, the permeabilizing activity of the labeled
peptide on single GUVs is comparable to that of the unla-
beled peptide (Fig. S5 B). The yield of GUV formation in
the presence of Alexa647-Baxa5 was low, and the distribu-
tion of the peptide among individual vesicles within the
same batch was found to be inhomogeneous (see middle
image in Fig. 4 B, left). After addition of Alexa488, internal-
ization of the dye was observed for a fraction of the vesicles
that increased with the bulk P/L (Fig. 4B, right). The leakage
was always of the all-or-none type, again indicating that
graded leakage corresponds to equilibration. A dose-
response plot for bulk P/L values (Fig. 4 A, triangles)
suggests a threshold P/L for the onset of equilibrium pores
near 1/25, which is larger than that extracted from the trend
of peptide-added systems (~1/100).We recall that the activity
registered with reconstituted LUVs also tends to be smaller
than that measured after a few hours in the presence of
peptide (Fig. 2). This may indicate that the peptide-added
systems were still not equilibrated after 2 h of incubation
with the peptide, althoughwe are cautious about this compar-
ison because of the differences between the two types of
samples.
Up to this point, we are characterizing leaky or pore states
of vesicles more than individual pores. We may by now
conclude that the vesicle pore state acquired through equil-
ibration, both in GUVs and LUVs, either maintains or trans-
forms into a long-term and eventually stable (equilibrium)
pore state. There also seems to be a threshold P/L value
for the onset of both types of pores, which is probably larger
at equilibrium, but below saturation, porated and nonporated
vesicles coexist and stay in stable or metastable states that
do not exchange appreciably among each other.Kinetic and long-term pores differ at least in size
An important question is, do the initial (kinetic or out-
of-equilibrium) pores have properties similar to those
observed at long term? Although this is difficult to answer,
we addressed it by testing the entry of dyes of different sizes
and at different times after incubation with Baxa5. For this
purpose, we compared the entrance of Alexa555 (1.25 KDa)
and a ~10 KDa calcein-labeled dextran (FD10). FD10 has
a hydrodynamic radius of 2.3 nm (50), which is slightly
larger than the ~1.7 nm of the physiologically relevant cyto-
chrome c (51). Two hours after gently mixing a suspension
of GUVs with both dyes and Baxa5, we saw that any chosen
FIGURE 5 Pores shrink with equilibration. (A) Example GUV (labeled
with DiD, left) 2 h after mixing in a solution containing Baxa5, Alexa555
(middle), and fluorescence-dextran FD10 (right). (B) Both dyes leak into
the vesicle, starting simultaneously and proceeding at similar rates.
However, for FD10 (dashed) the communication with the external pool
slowed down at some time point and eventually stopped before complete
filling occurred. (C) Continuing irradiation at 488 nm for 2 min bleached
the FD10 fluorescence only from the inside of the GUV. (D) In a separate
experiment, DiD-labeled GUVs were first put in a solution with Baxa5
and Atto655 to identify GUVs porated at short times (left). Two hours later,
Alexa555 and FD10 were added together and the vesicles were observed.
Vesicles that initially were completely permeable to Atto655 (as in the
example shown) were subsequently also fully permeable to Alexa555
(middle) but not to FD10 (right). The experiments correspond to a bulk
P/L of 1/22.5.
Equilibrium Pores of Baxa5 2923individual GUV that was permeable for the Alexa dye
(Fig. 5 A, middle) had also allowed entry of FD10 (Fig. 5
A, right). As explained above, for a given vesicle the onset
of the porated state is normally delayed and stochastic. A
recording of the kinetics (Fig. 5 B) shows that both fluores-
cence molecules start entering into the same vesicles simul-
taneously and initially at a very similar rate. However,
whereas the entry of Alexa proceeds smoothly up to
complete equilibration with the external pool, the entry of
FD10 is slowed down near the end of the kinetics (compare
solid and dashed lines in Fig. 5 B). This indicates that
although the pores initially were sufficiently large to allow
entry of FD10, they relaxed to a smaller size in a few
minutes. In fact, we observed that continued irradiation
bleached the fluorescence of FD10 only from the inside of
the GUV (Fig. 5 C), indicating that FD10 had becomeentrapped and could no longer reequilibrate with the outside
pool. To confirm the smaller size of long-term pores, in an
independent experiment we monitored the entry of
Alexa555 and FD10 added simultaneously to a GUV
suspension that was previously incubated with Baxa5 for
2 h. Initially porated GUVs, distinguishable by the complete
entrance of Atto655 (present in the external solution from
the beginning; Fig. 5 D, left), allowed immediate and
complete entry of added Alexa555 (Fig. 5 D, middle).
However, the same GUVs were very weakly permeable to
FD10, which was found to penetrate only to ~12% even
30 min after addition (Fig. 5 D, right). Considering the
approximate size of FD10, we can estimate that the initial
pores have a diameter that is clearly larger than ~4.6 nm
(6), but they shrink as they relax to a diameter smaller
than (but probably not far from) ~4.6 nm.
Pore shrinkage is in agreement with the significantly
smaller dye flux found in successive leakage events
(Fig. 3, E and F). A reduction in size after an initial burst
was also previously observed for purely lipidic pores
induced by tension, which typically relaxed until they
closed (52). However, although Baxa5-induced pores start
reducing in size quickly after they form, the peptide stabi-
lizes them, avoiding complete closure. On the basis of
a kinetic analysis, it was also suggested that the pores
formed by melittin shrink with equilibration (27). Such
observations can be related to a general role of amphipathic
peptides in the stabilization of lipidic pores, as proposed on
the basis of theoretical arguments (53) and other single-
vesicle experiments (10).
Our data in the case of Baxa5 provide further evidence
that preequilibrium and equilibrium pores, although likely
related, are not identical. Preequilibrium pores can be seen
as a response of the membrane to peptide adsorption in
the accessible monolayer. A molecular mechanism for such
a situation has been proposed on the basis of molecular-
dynamics simulations (16). The increased interfacial area
creates a tension that makes the membrane rupture. In prin-
ciple, this should occur simply above a certain limit of
tension, related to a limit of area stress and a limit of bound
peptide per unit area. However, in an asymmetrically
expanded bilayer, the packing of the compressed monolayer
is expected to significantly increase the activation energy for
membrane rupture (54). In such a strained metastable state,
pores initiate stochastically at points of nucleation of
defects. On the other hand, pore formation can generally
be assisted by molecules perturbing the packing of the lipids
(52,54), in which membrane-adsorbing peptides should also
play a role. The onset of peptide-induced pores must be
accompanied by a reorganization of the peptide-membrane
complex. In turn, the preequilibrium pores themselves
may help equilibration of the peptide across the bilayer, as
observed in other cases such as magainin 2 and melittin
(12,27). However, as the mass imbalance dissipates, the
pores of the all-or-none type do not close as is frequentlyBiophysical Journal 99(9) 2917–2925
2924 Fuertes et al.assumed. Instead, they relax into stable structures that are at
least smaller than the preequilibrium pores. It is reasonable
to speculate that the stable pores would also be more orga-
nized structures.
Finally, an interesting issue is the relevance of equilibrium
pores versus kinetic or preequilibrium pores. Other peptides
that follow an all-or-none mechanism, such as magainin (20)
and cecropin (14), may also form stable pores at equilibrium.
On the other hand, peptides that display a graded kinetics of
leakage (48) can be expected to form mainly transient pores.
From a practical point of view, the structure of transient pre-
equilibrium pores is difficult, if not impossible, to charac-
terize. Not surprisingly, the structural information that is
normally available corresponds to equilibrated peptide-
membrane complexes. Additionally, from a physiological
point of view, it is likely that the function ofmembrane-active
peptides occurs mainly through preequilibrium pores. The
fact that the action of antimicrobial peptides on individual
bacteria appears to be delayed and stochastic (18), in
a manner similar to the action over single vesicles, supports
this hypothesis. This is less clear for the case of pore-forming
proteins, where the process is mechanistically more complex
and regulated, and may need to extend to longer times or
involve different steps. In this sense, despite the simplicity
of the Baxa5 fragment, the stable pores reported here may
well be mechanistically relevant for the function of the
full-length protein (55,56). Although they are still not well
characterized, the pores formed by the protein Bax are likely
stable and organized structures (57,55), and this work shows
that the short sequence of the a5 fragment codifies the neces-
sary information to induce and stabilize pores, at least in
POPC and POPC/CL membranes. This would be a specific
property of this domain of Bax, in comparison with equiva-
lent fragments of other Bcl-2 proteins of a different type
(4), that has been selected through evolution to contribute
to the function of Bax.CONCLUSIONS
In summary, this study shows that the Baxa5 peptide in
POPC and POPC/CL membranes induces and stabilizes
long-lived pores that exist at equilibrium in both suspen-
sions of LUVs and individual GUVs. These pores appear
to be mechanistically related to preequilibrium pores, as
the first ones are formed in the same vesicles after relaxation
of the second. However, the equilibrium pores differ from
kinetic pores at least in size, since they exhibit a detectable
shrinkage in diameter, suggesting that they may correspond
to a different structural organization of the peptide-lipid
complexes.SUPPORTING MATERIAL
One table and five figures with statistical details about the analyzed GUVs
(Table S1), quantitative analysis of dye entrance kinetics in GUVs (Fig. S1),Biophysical Journal 99(9) 2917–2925kinetics of calcein release (Fig. S2) and quenching of NBD-PE lipids in
LUVs (Fig. S3), successive leak-in kinetics in GUVs (Fig. S4), and control
experiments for GUVs reconstituted with labeled Bax-a5 are available at
http://www.biophysj.org/biophysj/supplemental/S0006-3495(10)01086-6.
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